| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fulcrum Therapeutics, Inc. (FULC) has 11 insiders with recent SEC Form 4 filings, including 7 buys and 11 sells. FULC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.85M | $60.54M | - | |
| Dir | 469.9K | $3.21M | - | |
| Dir | 36.0K | $246.2K | - | |
| Dir | 36.0K | $246.2K | - | |
| Dir | 36.0K | $246.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 13, 2023 | Gould Robert J85 | Interim President &CEO | Sell | 6,766 | $15.00 | $101,490.00 | -1.3% | -81.7% | -48.2% | |
| Jan 4, 2023 | Ra Capital Management, L.P.52 | 10% Owner | Buy | 180,703 | $7.28 | $1,314,805.84 | +0.9% | -68.4% | -10.5% | |
| Dec 27, 2022 | Ra Capital Management, L.P.52 | 10% Owner | Buy | 4,089 | $5.99 | $24,509.87 | - | -48.3% | +11.8% | |
| Dec 19, 2022 | Ra Capital Management, L.P.52 | 10% Owner | Buy | 98,787 | $5.90 | $582,813.66 | +1.1% | -42.9% | -2.0% | |
| Dec 16, 2022 | Ra Capital Management, L.P.52 | 10% Owner | Buy | 2,403,049 | $5.44 | $13,073,873.91 | +10.5% | -31.2% | +0.7% | |
| Jun 7, 2022 | Gould Robert J85 | Director | Sale+OE | 71,435 | $8.09 | $577,894.86 | -12.4% | -7.3% | -60.9% | |
| Jun 6, 2022 | Gould Robert J85 | Director | Sale+OE | 66,622 | $8.00 | $532,809.94 | -4.2% | -0.8% | -58.2% | |
| Apr 7, 2022 | Gould Robert J85 | Director | Sale+OE | 5,631 | $24.02 | $135,228.47 | -1.1% | -76.5% | -89.6% | |
| Apr 5, 2022 | Gould Robert J85 | Director | Sale+OE | 94,251 | $24.16 | $2,276,683.71 | -5.8% | -77.0% | -89.9% | |
| Aug 11, 2021 | Stuart Bryan | See Remarks | Sale+OE | 60,000 | $20.42 | $1,225,000.00 | -100% | -3.6% | -62.5% |